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Abstract
Male circumcision reduces acquisition of HIV-1 by 60%. Hence, the foreskin is an HIV-1 entry portal during sexual transmission.
We recently reported that efficient HIV-1 transmission occurs following 1 h of polarized exposure of the inner, but not outer,
foreskin to HIV-1-infected cells, but not to cell-free virus. At this early time point, Langerhans cells (LCs) and T-cells within the
inner foreskin epidermis are the first cells targeted by the virus. To gain in-depth insight into the molecular mechanisms
governing inner foreskin HIV-1 entry, foreskin explants were inoculated with HIV-1-infeceted cells for 4 h. The chemokine/
cytokine milieu secreted bythe foreskintissue, andresultingmodifications indensity andspatial distributionof T-cellsandLCs,
were then investigated. Our studies show that in the inner foreskin, inoculation with HIV-1-infected cells induces increased
CCL5/RANTES (1.63-fold)anddecreased CCL20/MIP-3-alpha (0.62-fold) secretion.Elevated CCL5/RANTES mediates recruitment
of T-cells from the dermis into the epidermis, which is blocked by a neutralizing CCL5/RANTES Ab. In parallel, HIV-1-infected
cells mediate a bi-phasic modification in the spatial distribution of epidermal LCs: attraction to the apical surface at 1 h,
followed by migration back towards the basement membrane later on at 4 h, in correlation with reduced CCL20/MIP-3-alpha
at this time point. T-cell recruitment fuels the continuous formation of LC-T-cell conjugates, permitting the transfer of HIV-1
captured by LCs. Together, these results reveal that HIV-1 induces a dynamic process of immune cells relocation in the inner
foreskin that is associated with specific chemokines secretion, which favors efficient HIV-1 entry at this site.
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Introduction
According to an updated report on the global AIDS epidemic
(see www.unaids.org), 15 million men are currently infected with
HIV-1 worldwide. HIV-1 infection in men has recently gained
extensive scientific and public attention following reports of three
clinical trials, which clearly demonstrated that male circumcision
provides 60% protection from HIV-1 acquisition [1–3]. These
reports confirmed a multitude of previous similar epidemiological
observations [4], and suggest altogether an important role of the
male foreskin as an entry portal for HIV-1.
The male foreskin is a stratified epithelium, made of multiple
layers of keratin-forming epithelial cells (i.e. epidermis) positioned
on top of a connective tissue made of collagen-producing
fibroblasts (i.e. dermis) [5]. The foreskin consists of two different
aspects, outer and inner, which are easily distinguished by the
relative decrease in melanocytes in the inner foreskin [6]. While
some studies, including ours, have reported that the degree of
keratinization of the outer foreskin is higher than that of the inner
[7–10], other studies reached opposite conclusions [11] or
reported no difference in the degree of foreskin keratinization
[12]. Hence, a standardized method to evaluate keratin thickness
is required, in order to determine morphologically the difference
in keratinization between the outer and inner foreskins, which may
provide a protective barrier against HIV-1 entry [7,9,10,13].
Both foreskin epidermis and dermis also contain various
immune cells, such as Langerhans cells (LCs), T-cells, dendritic
cells (DCs) and macrophages [6–8,10,14–16]. These immune cells
may serve as potential targets for HIV-1 due to their expression of
CD4/CCR5, the principal receptors for HIV-1 [6–8,10,14,16,17],
as well as alternative HIV-1 attachment receptors, such as the C-
type lectins langerin on LCs and Dendritic Cell-Specific
Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-
SIGN) on DCs [10,15,18–22]. Two previous studies showed that
the foreskin is susceptible to entry of high doses of cell-free HIV-1
at time points of .24 h [7,16]. However, until recently, the exact
mechanisms responsible for HIV-1 entry into the foreskin,
especially during the very first hours following exposure of the
foreskin to HIV-1, remained to a large extent unknown.
To describe the initial events of HIV-1 foreskin entry, we
recently developed two novel and complementary models of the
adult human foreskin epithelium, namely ex-vivo polarized inner
PLoS Pathogens | www.plospathogens.org 1 June 2011 | Volume 7 | Issue 6 | e1002100and outer foreskin explants, and immuno-competent stratified
foreskin epithelia reconstructed in-vitro from isolated primary inner
or outer foreskin cells [10]. In these models, efficient HIV-1
transmission occurs following 1 h of polarized exposure of the
inner, but not outer, foreskin to mononuclear cells highly infected
with HIV-1, but not to cell-free virus [10]. Hence, within the inner
foreskin, in a first step, HIV-1-infected cells form viral synapses
with apical foreskin epithelial cells, leading to polarized budding of
HIV-1; In a second step, HIV-1 is rapidly internalized by
epidermal LCs and remains intact within their cytoplasm; In a
third step, LCs transfer HIV-1 to T-cells within the foreskin
epidermis, across conjugates formed between these two cell types
[10]. Together, these studies identified the foreskin region
permissive to HIV-1 (i.e. the inner foreskin), the conditions
allowing for efficient viral entry (i.e. virus originating from infected
cells), and the initial cells targeted by HIV-1 (i.e. LCs and T-cells).
In the present study, we now explore the molecular mechanisms
responsible for potent inner foreskin HIV-1 entry. Thus, our
recently developed polarized foreskin explants were inoculated
with HIV-1-infeceted or non-infected cells for 4 h. Following viral
exposure, the chemokine/cytokine milieu secreted by the foreskin
tissue was examined, as well as any related changes in the density
and spatial distribution of T-cells and LCs. The involvement of
selective chemokines in these processes was confirmed using
relevant blocking Abs. The results presented herein demonstrate
specific regulation of chemokines secretion within the inner
foreskin, correlating with a dynamic process of HIV-1 target cell
migration, which may govern the efficient entry of HIV-1 at this
site.
Results
HIV-1-infected cells affect specific chemokines secretion
by the inner foreskin
T-cells and LCs are the first cells targeted by HIV-1 during
early viral exposure of the inner foreskin [10]. The motility of
these migratory cells dependents on environmental cues, such as
chemokines and cytokines secreted by the tissue. To first screen for
potential chemokines and cytokines secreted by the foreskin, inner
foreskin explants were inoculated in a polarized manner for 4 h at
37uc with either non-infected or HIV-1-infected peripheral blood
mononuclear cells (PBMCs). Explants were then washed and
further incubated in culture medium in a non-polarized manner
overnight at 37uc, to permit the secretion of high/detectable
chemokines/cytokines levels. Quantitative multiplex bead immu-
noassay and flow cytometry or specific ELISA was then used to
measure the levels of twelve chemokines/cytokines.
Exposure of inner foreskin explants to non-infected PBMCs
(serving as negative control) resulted in different levels of
chemokines/cytokines secretion: no secretion of IL-23, IL-17A,
IL-10 and IL-1 beta; low levels of IFN gamma (,20 pg/ml);
moderate levels of CCL3/MIP-1 alpha, CCL20/MIP-3 alpha,
and CCL5/RANTES (100–1000 pg/ml); and high levels of
CCL2/MCP-1, CXCL8/IL-8, IL-6 and CXCL10/IP-10 (2500–
18500 pg/ml).
Next, to identify chemokines/cytokines whose secretion was
specifically affected by the interaction of HIV-1 with the tissue, the
measured levels following inoculation with HIV-1-infected
PBMCs were normalized to that following inoculation with non-
infected PBMCs. This enables the calculation of folds increase/
decrease secretion. Among the chemokines/cytokines secreted by
the inner foreskin, the levels of the highly secreted ones (i.e.
CCL2/MCP-1, CXCL8/IL-8, IL-6 and CXCL10/IP-10) were
not changed by the presence of HIV-1 (Fig. 1A). In contrast,
following inoculation with HIV-1-infected PBMCs, the chemo-
kines/cytokines secreted at low/moderate levels were either
decreased, including IFN gamma, CCL3/MIP-1 alpha and
CCL20/MIP-3 alpha (Fig. 1B, grey bars; mean actual values
were 13.8, 590.5 and 443.0 pg/ml following inoculation with non-
infected PBMCs and 4.0, 310.1 and 276.9 pg/ml following
inoculation with HIV-1-infected PBMCs, respectively; n=2), or
increased, including CCL5/RANTES (Fig. 1B, black bar; mean
actual values were 580.3 pg/ml following inoculation with non-
infected PBMCs and 953.6 pg/ml following inoculation with
HIV-1-infected PBMCs, respectively; n=2). Of note, in outer
foreskin explants (from the same individuals and tested in parallel
experiments), CCL5/RANTES was also secreted at moderate
levels, but remained unchanged following exposure to HIV-1-
infected PBMCs (mean actual values were 291.5 pg/ml following
inoculation with non-infected PBMCs and 354.3 pg/ml following
inoculation with HIV-1-infected PBMCs, respectively; n=2,
p=0.3451, Student’s t-test).
To further examine whether these alterations in chemokines
secretion were already detectable at the end of the infection
period, inner foreskin explants were inoculated in a polarized
manner for 4 h at 37uc with either non-infected or HIV-1-infected
PBMCs, and the apical and basal supernatant fractions were
collected immediately. A second array consisting of glass slides
spotted with capture Abs to either CCL5/RANTES or CCL20/
MIP-3 alpha, as well as specific CCL20/MIP-3 alpha ELISA,
were then used to evaluate the early-secreted levels of both
chemokines. The obtained values (i.e. arbitrary relative fluorescent
intensities using slides or pg/ml using ELISA) were translated to
folds increase/decrease secretion.
Although the secretion levels of both chemokines at this early
time point were lower and variable among foreskin tissues from
different individuals, inoculation with HIV-1-infected PBMCs
modified the secretion of CCL5/RANTES and CCL20/MIP-3
alpha in inner foreskin explants in a similar fashion to that
observed at later time points. Hence, compared to non-infected
PBMCs, exposure to HIV-1-infected PBMCs resulted in an
Author Summary
Circumcision reduces HIV-1 acquisition in men, suggesting
that the foreskin is an HIV-1 entry site. We previously
showed that two types of immune cells in the foreskin
epidermis are the first ones targeted by HIV-1. Hence,
Langerhans cells (LCs) positioned in proximity to the
external surface rapidly capture incoming HIV-1. The
internalized virus is then transferred to T-cells positioned
deeper within the epidermis. Herein, we studied the
molecular mechanisms affecting the movement of these
motile cells by testing whether HIV-1 alters the secretion of
foreskin chemokines (i.e. molecules that influence cell
migration). Our results show that HIV-1 increased the
secretion of CCL5/RANTES, a potent T-cell chemokine,
which mediated T-cell recruitment into the epidermis. In
parallel, HIV-1 decreased the secretion of CCL20/MIP-3
alpha, a potent LC chemokine, enabling LCs to travel
deeper into the tissue. The two cell types then ‘meet’ to
form close contacts that permit the transfer of the virus
from LCs to T-cells within the epidermis. Together, these
results reveal that HIV-1 modifies foreskin chemokines
secretion and the subsequent relocation of its initial
immune target cells. Therefore, blocking the responsive-
ness to these chemokines clinically may limit the local
spread of HIV-1 within the foreskin.
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apical supernatant fraction (mean fold increase6SEM of
1.39760.045 from n=3 explants; p=0.0419, Student’s t-test).
In parallel, exposure to HIV-1-infected PBMCs resulted in a
decrease in early CCL20/MIP-3 alpha that was secreted both
apically and basally (mean folds increase6SEM of 0.52160.183
apical and 0.55860.163 basal from n=3 explants; p=0.0345 and
0.0411, respectively, Student’s t-test).
Finally, immunohistochemical staining of inner foreskin ex-
plants for CCL5/RANTES expression showed that this chemo-
kine was expressed by foreskin keratinocytes. Unfortunately,
despite using several CCL5/RANTES Abs, the detected signals
were low and similar in all conditions, thus not permitting for
quantitative evaluation of the differences in CCL5/RANTES
levels following exposure to either non-infected or HIV-1-infected
PBMCs. Immunohistochemistry appears therefore not sensitive
Figure 1. HIV-1-infected cells affect secretion of chemokines by the inner foreskin. Inner foreskin explants were inoculated in a polarized
manner for 4 h with either non-infected or HIV-1-infected PBMCs, washed, and further incubated in medium in a non-polarized manner. The levels of
twelve chemokines and cytokines were measured the next day in the culture supernatants, using a custom multiplex bead immunoassay and
quantified by flow cytometry or specific ELISA. Shown are mean folds6SEM secretion of each analyte (derived from two independent explants),
calculated as [secretion after exposure to HIV-1-infected PBMCs/secretion after exposure to non-infected PBMCs], for either chemokines/cytokines
not altered (A) or altered (B) following exposure to HIV-1-infected cells. In (B), p=0.0105, 0.0308, 0.0166, 0.0045 for INF gamma, CCL3/MIP-1 alpha,
CCL20/MIP-3 alpha and CCL5/RANTES, respectively, Student’s t-test, n=2.
doi:10.1371/journal.ppat.1002100.g001
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observed by the more sensitive and quantitative methods we used
(i.e. ELISA and array slide) at this early time point.
These results show that HIV-1-infected PBMCs affect rapidly
the secretion of specific chemokines by the inner foreskin that
persists at later time points following viral exposure.
HIV-1-infected cells induce T-cells recruitment into the
inner foreskin epidermis
CCL5/RANTES exerts chemotactic activity on T-cells [23,24].
In the foreskin, the majority of T-cells are located within the
dermis, and a minority of T-cells are integrated within the
epidermis [6–8,10,14–16]. As secretion of CCL5/RANTES
increased in the inner foreskin epidermis upon early exposure to
HIV-1-infected PBMCs (see above), we next investigated possible
changes in T-cell density in inner foreskin following viral exposure.
Inner and outer foreskin explants were inoculated comparatively
with HIV-1-infected or non-infected PBMCs, and 4 h later the
explants were fixed, processed for immunohistochemistry, and
stained for CD3 expression. The number of the positively stained
CD3+ T-cells was then quantified in both epidermis and dermis.
Following 4 h inoculation with HIV-1-infected PBMCs, the
density of epidermal T-cells in the inner foreskin significantly doubled
(from 177631 to 370658; mean6SEM CD3+ cells/mm
2 epidermis
from n=3 experiments; p=0.0423, Student’s t-test; Fig. 2A). In
contrast, inoculation with non-infected PBMCs did not significantly
change the density of epidermal T-cells (from 151623 to 199634;
mean6SEM CD3+ cells/mm
2 epidermis from n=3 experiments;
p=0.3050, Student’s t-test; Fig. 2A). The difference between the
densities of epidermal T-cells following exposure to HIV-1-infected
compared to non-infected PBMCs at 4 h was significant (p=0.0316,
Student’s t-test). The increase in T-cell density in the inner foreskin
epidermis following exposure to HIV-1-infected PBMCs was
correlated with a significant decrease in their density within the
inner foreskin dermis (from 12016140 to 582658; mean6SEM
CD3+ cells/mm
2 dermis from n=3 experiments; p=0.0175,
Student’s t-test; Fig. 2A). Although the density of dermal T-cells
decreased following inoculation with non-infected PBMCs, the
changes were not statistically significant (p=0.2030, Student’s t-test;
Fig. 2A). The difference between the densities of dermal T-cells
following exposure to HIV-1-infected compared to non-infected
PBMCs at 4 h was significant (p=0.0269, Student’s t-test).
T-cell recruitment described herein is not a result of tissue entry
of the input PBMCs. Indeed, fluorescently loaded HIV-1-infected
input cells were never detected within the epithelium or the basal
compartment after their inoculation at the apical surface (data not
shown).
To gain further insight as to the identity of T-cells that entered
the epidermis, we performed additional double immunohisto-
chemical staining experiments of inner foreskin explants and
examined CD4 and CD8 expression on CD3+ T-cells. At 4 h, the
ratio of epidermal CD8 over CD4 T-cells was 8.961.3 following
inoculation with non-infected PBMCs. Following exposure to
HIV-1-infected PBMCs, the epidermal densities of both CD4+
and CD8+ cells increased, but the CD8 over CD4 ratio decreased
to 3.760.6 (p=0.0114, Student’s t-test, n=3), suggesting that
HIV-1-infected PBMCs induced preferential recruitment of CD4+
cells into the epidermis.
In agreement with these findings, the above-mentioned changes
corresponded with migration of T-cells from the dermal into the
epidermal compartments across a disrupted basement membrane,
as observed at the ultra-structural level in inner foreskin explants
following 4 h exposed to HIV-1-infected PBMCs (Fig. 2C).
In contrast, no statistically significant changes were observed in
the density of epidermal/dermal T-cells in parallel outer foreskin
explants exposed to either HIV-1-infected or non-infected PBMCs
(p=0.3873, 0.1333, 0.2355 and 0.2142 following exposure to
HIV-1-infected or non-infected PBMCs for either epidermis or
dermis, respectively; Student’s t-test; Fig. 2B). T-cells translocation
from the dermis into the epidermis was not observed at the ultra-
structural level in outer foreskin explants following 4 h exposure to
HIV-1-infected PBMCs.
These results suggest that HIV-1 originating from infected cells
recruits T-cells from the dermis into the epidermis in inner, but
not outer, foreskin.
CCL5/RANTES mediates T-cell recruitment into the inner
foreskin epidermis
T oi n v e s t i g a t ew h e t h e rt h ei n c r e a s ei nC C L 5 / R A N T E Ss e c r e t i o n
by the inner foreskin epidermis, detected after 4 h viral exposure, is
responsible for the observed T-cell recruitment (Fig. 2), a neutralizing
Ab to CCL5/RANTES was used. Hence, inner foreskin explants
from additional individuals were exposed for 4 h at 37uct oH I V - 1 -
infected PBMCs either: 1) alone; 2) in the presence of a control
isotype Ab; 3) or in the presence of a CCL5/RANTES neutralizing
Ab. Exposure to medium or non-infected PBMCs served as controls.
Following infection, epidermal single-cell suspensions were prepared,
stained for CD3 expression and examined by flow cytometry.
In agreement with our CD3+ cell counting by immunohisto-
chemistry (Fig. 2A), inoculation with HIV-1-infected PBMCs
resulted in a higher percentage of CD3+ cells in cell suspensions of
inner foreskin epidermis, compared to inoculation with either
medium of non-infected PBMCs (Fig. 3A, B). Pre-treatment of
inner foreskin explants with a control isotype Ab did not affect the
observed increase in CD3+ cells upon exposure to HIV-1-infected
cells (Fig. 3B, dark grey bar). In sharp contrast, a neutralizing Ab
to CCR5/RANTES completely abrogated T-cell recruitment into
the epidermis (Fig. 3B, light grey bar, 80 mg/ml Ab).
This set of results demonstrates that the recruitment of T-cells
into the inner foreskin epidermis induced by HIV-1-infected cells
depends on CCL5/RANTES.
LCs are retained within the inner foreskin epidermis and
capture HIV-1
LCs play a major role during the initial hours of HIV-1
exposure in both the male and female genital tracts, by sampling
the mucosal surface and rapidly internalizing HIV-1 that remains
intact within their cytoplasm [10,25]. In the foreskin, LCs are
located within the epidermis but not dermis [6–8,10,14,15].
To study possible changes in LC density mediated by HIV-1,
inner and outer foreskin explants were inoculated for 4 h with
either HIV-1-infected or non-infected PBMCs, stained for
langerin, and the numbers of langerin+ LCs were counted. In
the inner foreskin epidermis, LC density did not change upon
exposure to HIV-1-infected cells (from 5816124 to 554675;
mean6SEM langerin+ cells/mm
2 epidermis from n=3 experi-
ments; p=0.4305, Student’s t-test; Fig. 4A). In contrast,
inoculation with non-infected PBMCs resulted in a significant
decrease in LC density (from 597687 to 327664; mean6SEM
langerin+ cells/mm
2 epidermis from n=3 experiments;
p=0.0322, Student’s t-test; Fig. 4A), in correlation with detection
of langerin+ cells in the dermis at this time point (see Fig. 5 below).
The difference between the densities of epidermal LCs following
exposure to HIV-1-infected compared to non-infected PBMCs at
4 h was significant (p=0.0415, Student’s t-test). No statistically
significant changes were observed in the density of langerin+ cells
CCL5 Recruits Foreskin T-Cells for HIV-1 Entry
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infected or non-infected PBMCs (p=0.1578 and 0.1274, respec-
tively, Student’s t-test; Fig. 4B).
To investigate the co-localization of HIV-1 virions with LCs,
inner and outer foreskin explants were exposed for 4 h to HIV-1-
infected PBMCs, double stained for langerin and HIV-1, and
examined by confocal microscopy. The specificity of the signals
recorded was based on parametric settings using specific isotype
controls for either langerin or HIV-1 [10]. In inner foreskin,
langerin was detected around cell bodies, as well as in LC
dendrites reaching the apical surface (Fig. 4C, red arrowheads). In
these explants, HIV-1 was detected as free virions or associated
Figure 2. HIV-1-infected cells induce recruitment of T-cells into the epidermis. Parallel inner (A) and outer (B) foreskin explants were
exposed for 4 h to either HIV-1-infected (solid lines) or non-infected (broken lines) PBMCs. Explants were then stained with anti-CD3 Ab and
visualized with DAB peroxidase substrate. Shown are means6SEM CD3+ cell densities (cells/mm
2) in either epidermis or dermis derived from three
independent explants. Cells were counted in a minimum of 10 fields/section in each experiment. In (A): p=0.0423 and 0.0175, 4 h vs. 0 h for infected
epidermis and dermis, respectively; p=0.0316 and 0.0269, HIV-1-infected vs. non-infected at 4 h for epidermis and dermis, respectively; Student’s
t-test, n=3. (C) Electron micrograph of inner foreskin explant exposed for 4 h to HIV-1-infected PBMCs. Shown is a T-cell, identified by its typical
morphology and size/shape of nucleus, migrating into the epidermis across a disrupted basement membrane (non-continuous black dotted line). The
rear of the cell is still localized in the dermis. Scale bar=0.5 mm.
doi:10.1371/journal.ppat.1002100.g002
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arrowheads). Notably, HIV-1 was also found co-localized with
LCs (Fig. 4C, green arrows) including virions that were
internalized into LCs (Fig. 4C, higher magnification insert), and
was further detected within the dermis. In contrast, in outer
foreskin, only few virions were detected within the epidermis
(Fig. 4D), in agreement with our previous study [10].
These results suggest that HIV-1 originating from infected cells
enters the inner foreskin, and is captured by LCs retained in the
epidermis. In contrast, in outer foreskin, HIV-1 fails to enter the
epidermis or affect LC density.
HIV-1-infected cells modify the spatial distribution of LCs
in the inner foreskin
To follow the localization of LCs following HIV-1 exposure,
inner foreskin explants were exposed for 1 h or 4 h to either HIV-
1-infected or non-infected PBMCs, stained for langerin, and the
Figure 3. CCL5/RANTES mediates T-cell recruitment into the epidermis. (A) Representative FACS profiles out of two independent
experiments, showing epidermal single-cell suspensions derived from inner foreskin explants exposed for 4 h to either medium alone (left), non-
infected PBMCs (middle), or HIV-1-infected PBMCs (right). Cells were stained with PE-conjugated anti-human CD3 mAb and numbers represent the
percentages of CD3+ cells in the framed windows (determined based on the non-specific staining of a matched isotype control Ab). (B) Inner foreskin
explants were exposed for 4 h to either non-infected PBMCs (white bar) or HIV-1-infected PBMCs: alone (black bar); in the presence of 40 mg/ml
control goat IgG Ab (dark grey bar); in the presence of 20 or 80 mg/ml neutralizing goat Ab to CCL5/RANTES (light grey bars). Following infection,
epidermal single-cell suspensions were prepared and stained for CD3 expression as described above. Shown are mean folds increase6SEM of the
percentages of CD3+ cells, normalized against that following exposure to non-infected PBMCs and derived from two independent explants.
p=0.0129 infected vs. non-infected and p=0.0128 infected+CCL5 Ab 80 mg/ml vs. infected; Student’s t-test.
doi:10.1371/journal.ppat.1002100.g003
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PLoS Pathogens | www.plospathogens.org 6 June 2011 | Volume 7 | Issue 6 | e1002100Figure 4. (A, B) HIV-1-infected cells induce retention of LCs within the epidermis. Parallel inner (A) and outer (B) foreskin explants were
exposed for 4 h to either HIV-1-infected (solid lines) or non-infected (broken lines) PBMCs. Explants were then stained with anti-langerin Ab and
visualized with DAB peroxidase substrate. Shown are means6SEM langerin+ cell densities (cells/mm
2) in epidermis derived from three independent
explants. Cells were counted in a minimum of 10 fields/section in each experiment. In (A): p=0.0322 non-infected epidermis 4 h vs. 0 h and
p=0.0415 HIV-1-infected vs. non-infected at 4 h; Student’s t-test. (C, D) HIV-1 entry and capture by LCs in inner, but not outer, foreskin explants.
Single sections observed by confocal microscopy of parallel inner (C) and outer (D) foreskin explants, following 4 h exposure to HIV-1-infected PBMCs.
Horizontal and vertical lines represent the localization of the sectioned stacks along the z axis (25 sections, 0.2 mm apart) that are shown below and to
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(irrespective of their HIV-1 content) were measured. Similar
distances were also measured in normal inner foreskin, serving as
the set point for the spatial distribution of LCs.
Inoculation with non-infected PBMCs resulted in a time-
dependent increase in the mean distance of LCs from the apical
surface compared to normal inner foreskin (Fig. 5A). Thus, at 1 h
LCs were localized closer to the basement membrane and at 4 h
LCs crossed the epidermis/dermis interface and reached the
dermis, localizing further away from the apical surface. In
contrast, exposure to HIV-1-infected PBMCs resulted in a bi-
phasic modification in LC spatial distribution, compared to
normal foreskin (Fig. 5A): after 1 h of viral exposure, the mean
distance of LCs from the apical surface shortened; at 4 hr these
cells were localized near the basement membrane, and fewer LCs
reached the dermis compared to exposure with non-infected
PBMCs.
Based on the above ‘snap-shot’ images and to calculate the total
distance covered by LCs during the 4 h infection period, the
following mean distances from the apical surface were designated:
[a] for normal tissue (set point distance); [b] and [c] after 1 h and
4 h inoculation with non-infected PBMCs, respectively; [d] and
[e] after 1 h and 4 h inoculation with HIV-1-infected PBMCs,
respectively (Fig. 5A). The mean distance covered by LCs
following 1 h exposure to non-infected PBMCs is therefore
represented by [b] minus [a], as LCs were localized away from
the apical surface. In contrast, the mean distance covered by LCs
following 1 h exposure to HIV-1-infected PBMCs is represented
by [a]-[d], as LCs were localized closer to the apical surface. At
4 h, the additional distances covered by LCs are represented as
[c]-[b] and [e]-[d], as LCs were localized away from the apical
surface following exposure to either non-infected or HIV-1-
infected PBMCs. This analysis (Fig. 5B, C) demonstrated that at
1 h post-infection, LCs covered a similar distance, but in opposite
directions (7.25960.606 mm basally and 5.64261.337 mm apically
after exposure to either non-infected or HIV-1-infected PBMCs,
respectively). Yet, LCs covered a shorter additional distance at 4 h
after exposure to non-infected, compared to HIV-1-infected
PBMCs (10.67761.218 mm and 21.65160.749 mm for non-
infected or HIV-1-infected PBMCs, respectively; p,0.0001,
Student’s t-test; Fig. 5C).
These findings suggest that LCs may directly exit the epidermis
following inoculation with non-infected cells. However, HIV-1
originating from infected cells induces first the attraction of LCs to
the apical surface at 1 h, followed by their entry deeper into the
tissue towards the epidermis-dermis interface at 4 h.
HIV-1-infected cells induces continuous formation of
LC-T-cell conjugates
Following the rapid internalization of HIV-1 by LCs in the
inner foreskin at 1 h, intact virions that are sequestered within LCs
are transferred to epidermal T-cells across conjugates forming
between LCs and T-cells [10]. The number of such LC-T-cell
conjugates was further evaluated at 4 h, in inner foreskin explants
inoculated with either HIV-1-infected or non-infected PBMCs and
double stained for langerin and CD3. The percentage of
langerin+/CD3+ conjugates out of the total number of langerin+
cells was then calculated. Of note, conjugates were defined as
those in which LCs and T-cells were in direct contact with a visible
interface and common segment of plasma membrane, while
excluding those in which LCs and T-cells were only in proximity
with a visible space between the two stained cells.
At 1 h, 4.561.1% LCs were conjugated with T-cells (Fig. 6A).
The proportion of conjugates continued to increase and almost
doubled at 4 h, with 7.662.1% of LCs forming conjugates with T-
cells (p=0.0431, Student’s t-test, Fig. 6A). These LC-T-cell
conjugates were located within the epidermis just above the
basement membrane (Fig. 4C), while conjugates were only
occasionally detected following exposure to non-infected PBMCs
(Fig. 6B). Higher magnification images revealed LCs to be tightly
associated with T-cells and HIV-1 virions (Fig. 6D, E).
In agreement with our conjugate counting by immunohisto-
chemistry (see above), inoculation with HIV-1-infected PBMCs
resulted in a higher percentage of langerin+/CD3+/high forward
scatter conjugates in cell suspensions of inner foreskin epidermis,
compared to inoculation with non-infected PBMCs (Fig. 6F). Pre-
treatment of inner foreskin explants with a control isotype Ab did
not affect the observed increase in conjugate formation upon
exposure to HIV-1-infected cells. In sharp contrast, a neutralizing
Ab to CCR5/RANTES inhibited the formation of LC-T-cell
conjugates induced by HIV-1-infected PBMCs (Fig. 6F).
These results suggest that LC-T-cell conjugate formation within
the inner foreskin tissue following exposure to HIV-1-infected cells
is a sustained process during the early hours following exposure to
HIV-1.
Discussion
HIV-1 is a viral menace that gains access into the body mainly
during sexual intercourse, by crossing epithelial barriers that cover
the mucosal surfaces of the gastrointestinal, female and male
genital tracts. In stratified epithelia, HIV-1 ‘highjacks’ the
physiological process of pathogen recognition by LCs [26] in
order to invade the body. In the inner foreskin [9,10] and vagina
[25], early HIV-1 transmission involves capture of HIV-1 by
epidermal LCs. These cells are able to internalize intact HIV-1
virions, due to their close proximity to the mucosal surface and
their ability to bind the HIV-1 envelope glycoprotein subunit
gp120 via their unique C-type lectin langerin [19,21,22]. The
internalized intact virus is then transferred to T-cells locally within
the epithelium [10,25]. Hence, LCs and T-cells are the first cells
targeted by HIV-1 in both the male and female genital tracts early
upon exposure to HIV-1.
To gain further insight as to the molecular/cellular dynamics of
HIV-1 entry in the foreskin, we used in the current study our
recently developed foreskin explants [10], which permit for
polarized exposure to the virus only via the apical side, as takes
place in-vivo. Foreskin explants were inoculated comparatively for
4 h with HIV-1-infected or non-infected cells, as our previous
study clearly demonstrated that foreskin transmission of cell-
associated HIV-1 is much more efficient compared to that of cell-
free virus [10]. In line with these observations, a limited number of
studies aimed at ascertaining the infectivity of cell-associated
the right of each image. Sections were double-stained with goat-anti-human langerin Ab followed by TRITC-conjugated anti-goat IgG Ab and a
mixture of several human/mouse anti-HIV-1 mAbs followed by FITC-conjugated anti-human/mouse IgG Abs. In (C), langerin is detected around cell
bodies and dendrites reaching the apical surface (red arrowheads); HIV-1 virions are detected as dots in the epidermis associated with epithelial cells
or in dermis (green arrowheads), as well as co-localized with LCs (green arrows). Higher magnification image with the xyz planes rotated shows viral
particles internalized into LCs. Cell nuclei were counterstained with DAPI. White dotted lines denote the epidermis/dermis interface. Scale
bars=10 mm. Representative images of n=3 experiments.
doi:10.1371/journal.ppat.1002100.g004
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reported that cell-associated HIV-1 was transmitted more
efficiently compared to cell-free virus (e.g. [27], and recently
reviewed in [28]).
To explore the possible molecular mechanisms that might affect
the migratory behavior of T-cells and LCs in the foreskin, we
measured the levels of several chemokines and cytokines that may
be secreted by the inner foreskin tissue. Our results show that the
inner foreskin produces high levels of CCL2/MCP-1, CXCL8/IL-
8, IL-6 and CXCL10/IP-10, in line with a recent study that
documented a similar patter of secretion in inner foreskin explants
[16]. However, HIV-1-infected cells do no affect the secretion of
these chemokines/cytokines (Fig. 1), suggesting that these
molecules probably do not contribute to the observed modifica-
tions in the spatial distribution of T-cells/LCs reported herein that
are mediated by HIV-1-infected cells. In contrast, HIV-1-infected
cells up-regulate CCL5/RANTES and down-regulate CCL20/
MIP-3 alpha secretion, during both the first and late hours
following viral inoculation. We speculate that at the early time
points, chemokine secretion represents the levels of pre-synthe-
sized/stored chemokines, rather then de-novo synthesis. Hence, the
exact mechanisms by which HIV-1-infected cells modify early/late
chemokine secretion may differ.
Of note, the PHA/IL-2 activated PBMCs used herein may
differ from naturally occurring HIV-1-infected cells in genital
secretions and may secrete chemokines due to their experimental
activation. Although both non-infected/HIV-1-infected cells
secreted CCL5/RANTES and CCL20/MIP-3 alpha when
incubated alone, without contact with the foreskin tissue, the
secreted levels did not differ between non-infected and HIV-1-
infected cells and were low (data not shown). In contrast,
chemokines secretion was always higher in the supernatant
fractions upon inoculation with the tissue explants, suggesting
that the contact between HIV-1-infected cells and the inner
foreskin tissue results in the observed modifications in chemokines
secretion, which may be contributed by the cells themselves, the
tissue, or both.
By measuring the density of T-cells in both the foreskin
epidermis and dermis, we reveal herein that HIV-1-infected cell
induce T-cell recruitment from the dermis into the epidermis, as
the density of epidermal T-cell increases, in correlation with a
decrease in their density in the dermis (Fig. 2). This process is
restricted to the inner foreskin, as T-cell density remains
unchanged in the outer foreskin, in line with previous studies
including our own, showing that the inner, but not outer, foreskin
is permissive to HIV-1 entry [7,10]. Importantly, our studies
clearly show that CCL5/RANTES, a known T-cell chemokine
[23,24], which is increased following inoculation with HIV-1-
infected cells, is responsible for such T-cell recruitment, as an
activity neutralizing Ab to CCL5/RANTES completely abrogates
this process (Fig. 3). This principal finding is in line with a recent
study showing that CCL5/RANTES mediates specific recruitment
of T-cells in human skin xenografts in-vivo [29]. Another study
reported that treatment of inner foreskin explants for several days
with the chemokine CCL3/MIP-1 alpha, but not with several
others, induces T-cell infiltration into the epidermis [30].
However, as we show herein, CCL3/MIP-1 alpha secretion is
decreased in inner foreskin explants following exposure to HIV-1
at such late time points (Fig. 1), suggesting that virus-mediated
recruitment of T-cell into the epidermis does not involve this
chemokine. Interestingly, the CCL5/RANTES neutralizing Ab
used herein not only prevents epidermal T-cell recruitment, but
apparently also facilitates exit of T-cell from the epidermis (i.e. the
fold value in Fig. 3B is 0.7260.10 for 80 mg/ml neutralizing Ab).
This observation suggests that endogenous tissue CCL5/RANTES
has a physiological role in maintaining T-cells within the
epidermis.
In addition, we show that HIV-1-infected cells do not affect the
density of epidermal LCs (Fig. 4), but rather modify their spatial
distribution (Fig. 5). Hence, HIV-1-infected cells first induce
attraction of LCs to the apical surface, and only later LCs travel
towards the basement membrane. In fact, during the first hour of
Figure 5. HIV-1-infected cells modify the spatial distribution of
LCs in inner foreskin. (A) Representative images of normal inner
foreskin (top), and inner foreskin explants exposed to either non-
infected (left) or HIV-1-infected (right) PBMCs for 1 h (middle) or 4 h
(bottom). Explants were then stained with anti-langerin Ab and
visualized with AEC (normal foreskin) or DAB (foreskin explants)
peroxidase substrates. The black double-headed arrows denote
individual distances of LCs from the apical surface for each condition
and are marked as [ai]-[ei] respectively. Images are representative of
three independent experiments. Scale bars=20 mm. (B) Calculated
mean6SEM distances covered by LCs, following exposure of inner
foreskin explants to either non-infected (white bars) or HIV-1-infected
(grey bars) PBMCs. For exposure to non-infected PBMCs, the distances
after 1 h and 4 h were calculated as [b]-[a] and [c]-[b], respectively,
where a, b, c are means of the individual [ai], [bi], [ci] distances
(measured for 106, 193 and 148 different cells in three independent
explants). For exposure to HIV-1-infected PBMCs, the distances after 1 h
and 4 h were calculated as [a]-[d] and [e]-[d], respectively, where d and
e are mean of the individual [di] and [ei] distances (measured for 186
and 108 different cells in three independent explants). *p,0.0001
infected vs. non-infected at 4 h; Student’s t-test. (C) shows the actual
distances from the apical surface measured for each experimental
condition. *p,0.0001 vs. normal foreskin; Student’s t-test.
doi:10.1371/journal.ppat.1002100.g005
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PLoS Pathogens | www.plospathogens.org 9 June 2011 | Volume 7 | Issue 6 | e1002100Figure 6. HIV-1-infected cells increase the formation of epidermal LC-T-cell conjugates. (A) Inner foreskin explants were exposed for 1 h
or 4 h to HIV-1-infected PBMCs. Explants were then double stained with anti-langerin and anti-CD3 Abs, and visualized with DAB and HistoGreen
peroxidase substrates, respectively. Shown are calculated means6SEM % LC-T-cell conjugates of the total LCs from three independent explants. Cells
were counted in a minimum of 10 fields/section for each experiment. *p=0.0431 4 h vs. 1 h, Student’s t-test. (B–D) Representative images of inner
foreskin explants exposed to either non-infected (B) or HIV-1-infected (C and D) PBMCs for 4 h, and double stained for langerin (DAB brown in B and
C; Alexa488 green in D) and CD3 (Histogreen blue-green in B and C; Cy5 red in D). Single isolated non-conjugated LCs and T-cells are shown in the
framed window in (B), while the framed window in (C) shows LC-T-cell conjugate at the epidermal-dermal interface above the basement membrane
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directions: apically upon exposure to HIV-1-infected cells and
basally upon exposure to non-infected cells. As measuring the
levels of secreted chemokines after 1 h is technically challenging,
the identity of the specific chemokines mediating these opposing
effects is currently an open question. Interestingly, the additional
migration distance covered by LCs later on after inoculation with
HIV-1-infected cells is higher compared to non-infected cells
(Fig. 5), suggesting that LCs are able to migrate more rapidly (i.e.
longer distance during the same time period). This observation
correlates with the decreased secretion levels of CCL20/MIP-3
alpha, the most potent chemokine for LCs [31], at this time point.
In contrast, inoculation with non-infected cells results in a gradual
increase in LC distance from the apical surface along with a
decrease in their epidermal density. This process probably reflects
the natural emigration of LCs out of the epidermis, a known
feature of these migratory cells that is routinely used experimen-
tally for their isolation form mucosal epithelia. We further
speculate that HIV-1 might have evolved the ability to modulate
chemokines secretion to mediate the initial attraction of LCs
apically, in order to facilitate its capture by LCs. This notion is
supported by our microscopy studies showing for the first time co-
localization of HIV-1 with LCs in-situ at the early hours following
viral exposure (Fig. 4). Such process could permit early local
spread of the virus to epidermal T-cells (either already present
within the epidermis and/or newly recruited from the dermis) and
establishment of an HIV-1-infected founder cell population that is
crucial for systemic dissemination of the virus later [32,33].
Comparatively, in the female genital tract, HIV-1 enters lamina
propria macrophages in explanted vaginal mucosa as early as
30 min after inoculation of virus onto the epithelium, and purified
vaginal macrophages support substantial levels of HIV-1 replica-
tion [34]. In contrast, within the foreskin, dermal macrophages/
DCs do not seem to participate in the early events of HIV-1 entry.
Their densities and spatial distributions in the dermis remain
completely unaffected by the presence of either HIV-1-infected or
non-infected cells (data not shown). In addition, intact HIV-1
virions may enter vaginal epithelial cells [35], and also inner
foreskin keratinocytes as shown here (Fig. 4). Whether these
sequestered virions affect foreskin keratinocytes to promote viral
entry is still unclear.
Productive infection of LCs with HIV-1 following viral capture
is limited, and may rely on langerin-mediated degradation of low
concentrations of HIV-1 [22] and expression of several host
factors that block HIV-1 replication [36,37]. In sharp contrast,
previous studies have clearly demonstrated that HIV-1 captured
by LCs can be efficiently transferred to T-cells across LC-T-cell
conjugates, to induce extensive replication of the virus in T-cells
[20,22,38–45]. In line with these studies, we recently reported that
within 1 h, LCs in the inner foreskin internalize intact HIV-1
virions, which are transferred to T-cells across LC-T-cell
conjugates forming rapidly within the epidermis [10]. In the
female genital tract, endocytosed virions persist in LCs and remain
accessible for transfer to conjugated vaginal T-cells [25]. Hence,
LCs serve as storage for HIV-1, facilitating its later spread to T-
cells.
Herein, we further followed the process of LC-T-cell conjugate
formation in the inner foreskin at later time points. Such
conjugated formation is initiated 1 h post HIV-1 inoculation
and appears to be a continuous process with increase in conjugate
numbers up to 4 h. Importantly, as LC density remains constant in
the inner foreskin epidermis (Fig. 4), while T-cell density increases
(Fig. 2), the recruitment of T-cell into the epidermis fuels this
continuous and sustained formation of LC-T-cell conjugates.
Thus, inhibiting the recruitment of T-cells into the epidermis may
turn clinically useful to limit the local spread of the virus.
Clinically approved CCR5 inhibitors [46–48] prevent HIV-1
infection of CCR5-expressing cells, and are also efficient
microbicides preventing vaginal transmission in female macaques
[49,50]. As demonstrated herein, CCL5/RANTES recruits T-cells
into the inner foreskin epidermis, which drives the continuous
process of LC-T-cell conjugate formation. Hence, CCR5
inhibitors may have a dual mechanism of action: directly
inhibiting HIV-1 infection, as well as decreasing mucosal T-cell
recruitment, to subsequently limit the local spread of the virus
from LCs to T-cells. Future studies will hopefully challenge this
notion, and examine the efficacy of CCR5 inhibitors as
microbicides aimed at preventing inner foreskin HIV-1 entry.
Based on our results, Fig. 7 summarizes the ‘chain-of-events’ of
early HIV-1 entry in the inner foreskin. At 1 h, the interaction of
HIV-1-infected cells with the inner foreskin leads to viral synapse
formation, HIV-1 budding and attraction of LCs to the apical
surface, which facilitates viral capture by LCs. At 4 h, LCs
harboring intact HIV-1 virions in their cytoplasm rapidly travel
towards the basement membrane, and T-cells are recruited from
the dermis into the epidermis, to fuel the continuous formation of
LC-T-cell conjugates within the inner foreskin epidermis. The re-
localization of LCs towards the basement membrane may result
from decreased secretion of CCL20/MIP-3, while recruitment of
T-cells results from increased CCL5/RANTES secretion, induced
by HIV-1-infected cells. Blocking the responsiveness to these
chemokines, for instance by CCR5 inhibitors already approved for
clinical use, may turn useful as a novel mechanism to limit the
local spread of HIV-1 within the inner foreskin epithelium, and
perhaps also other mucosal epithelia.
Materials and Methods
Ethics Statement
The study was performed according to local ethical regulations
following approval by the local ethical committee (Comite ´d e
Protection des Personnes (GHU Cochin-St vincent de Paul, Paris,
France). Written informed consent was provided by all study
participants and/or their legal guardians.
(black dotted lines). The confocal microscopy image in (D) shows the close contact between one LC and one T-cell, as well as the LC dendrite in
proximity to a second T-cell. Scale bars=20 mm (B, C) and 8 mm (D). (E) Electron micrograph of LC-T-cell conjugate in inner foreskin explant exposed
for 4 h to HIV-1-infected PBMCs. The conjugate is positioned within the epidermis at the epidermal-dermal interface above the basement membrane
(black dotted line); scale bar=1 mm. Higher magnification of the top framed window (right side) shows two rod-shaped Birbeck granule in the LC
cytoplasm (black arrows); scale bar=200 nm. Higher magnification of the bottom framed window (right corner) shows an HIV-1 particle of 90 nm
with a central dark core characteristic of mature virions associated with LC; scale bar=50 nm. ‘‘(F) Inner foreskin explants were exposed for 4 h to
either non-infected PBMCs (top right) or HIV-1-infected PBMCs: alone (bottom left); in the presence of 40 mg/ml control goat IgG Ab (bottom middle);
in the presence of 80 mg/ml neutralizing goat Ab to CCL5/RANTES (bottom right). Following infection, epidermal single-cell suspensions were
prepared and double stained with APC-conjugated anti-human langerin and PE-conjugated anti-human CD3 mAbs. Cells were first gated on
langerin+ cells (R1 gate, top left profile, insert shows staining with matched isotype control). Numbers represent the percentages of cells in R1 that
are both high forward scatter and CD3+. Images are representative of two independent experiments.
doi:10.1371/journal.ppat.1002100.g006
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Normal foreskin tissues were obtained from the Urology Service
at the Cochin Hospital, Paris, France, from healthy adults (mean
age 32 years old, range 18–57 years) undergoing elective
circumcision due to personal reasons or phimosis, and according
to local ethical regulations. Foreskin tissues removed due to
cancerous or infectious pathologies were discarded and not used.
Informed consents were obtained from all individuals. Tissues
were placed in phosphate-buffered saline (PBS) supplemented with
20 mg/ml gentamicin (Gibco Invitrogen, Carlsbad, CA), trans-
ported to the laboratory immediately following circumcision, and
processed within the next 2 h.
Foreskin tissues were separated mechanically into inner and
outer parts, distinguished by their different colors and morphol-
ogy, and any remaining fat and muscle tissue was removed from
the dermal side. Round pieces from either inner or outer foreskin
were cut using a 8 mm Harris Uni-Core, and placed with their
epidermal side facing up on top of a polycarbonate membrane
(12 mm pore size, 12 mm diameter) of a two-chamber Costar
Transwell permeable insert (Corning Inc, Corning, NY). Hollow
plastic cloning ring cylinders of 6 mm inner diameter (VMR,
Strasbourg, France) were glued to the apical surface of each tissue
piece, using the two-component biological fibrin sealant Tissucol
kit (Baxter Int., Vienna, Austria), as previously described [10].
Sealing efficiency of the polarized apical chambers was monitored
as previously described [10].
Virus and infected cells
PBMCs from healthy donors were separated from whole blood
by a standard Ficoll gradient. The HIV-1 primary isolate
93BR029 (clade B, R5 tropic; NIH AIDS reagent program) was
amplified on phytohaemagglutinin (PHA)-stimulated PBMCs as
described [51]. HIV-1 p24 antigen was quantified by the p24
Innotest HIV-1 ELISA (Innogenetics, Gent, Belgium), and viral
stocks were aliquoted for single use and stored at 280uc.
To obtain HIV-1-infected cells, PHA/IL-2 stimulated PBMCs
(5610
6 cells in 10 ml RPMI 1640 (Gibco) supplemented with 10%
fetal bovine serum (FBS; PAN Biotech GmbH, Aidenbach,
Germany), 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml
streptomycin (Gibco), and 10 U/ml IL-2 (Roche Diagnostics
GmbH, Mannheim, Germany)) were inoculated with 200 ng p24
of the HIV-1 primary isolate 93BR029. Two days later, further
non-infected PHA/IL-2 stimulated cells were added (20610
6 cells
in 10 ml of the same medium containing 20 U/ml IL-2). Infection
was monitored in culture supernatants by p24 ELISA and by p24
intracellular staining and flow cytometry analysis. Infected cells
were used between days 7–14 following addition of virus. Under
these infection conditions, 1610
6 infected cells released 100–
500 pg p24 after 1 hr incubation at 37uc, and 5–7% of the
infected cells were positive for p24.
Short-term polarized infection assay
Foreskin explants were exposed apically and in a polarized
manner to 1610
6 of either HIV-1-infected or non-infected
PBMCs (as negative control), in 100 ml RPMI 1640 added into
the inner space of the cloning ring cylinders adhered to the tissue
explants. Lower chambers were supplemented with 0.5 ml RPMI
1640. Following 4 h incubation at 37uc, explants were either fixed
in 4% paraformaldehyde (PFA) for further morphological
evaluation, or processed for preparation of epidermal single-cell
suspensions (see below). Alternatively, following the 4 h polarized
viral exposure, explants were washed and further incubated
overnight at 37uc in a non-polarized manner in 0.5 ml RPMI
1640. For measurement of secreted chemokines and cytokines, the
supernatants fractions were removed, centrifuged, inactivated at
56uc for 45 min, and stored at 280uc.
Quantification of secreted chemokines and cytokines
The levels of eleven chemokines and cytokines, secreted by
triplicate foreskin explants exposed to either HIV-1-infected/non-
infected PBMCs (4 h polarized exposure followed by overnight
non-polarized incubation), were measured by a custom multiplex
bead immunoassay kit (Bender MedSystems, Vienna, Austria) and
quantified by flow cytometry, according to the manufacturer’s
instructions. Recorded profiles from flow cytometry were exported
and analyzed using the FlowCytomix Pro 2.3 Software (Bender)
enabling calculation of the concentration (pg/ml) of each analyte
in the tested samples. The levels of CCL20/MIP-3 alpha in
supernatants collected after similar exposure to the virus, or
following short-term polarized infection for 4 h, were quantified
with the Quantikine human MIP-3 alpha ELISA kit (R&D
systems, Minneapolis, MN), according to the manufacturer’s
instructions, and translated to actual concentrations (pg/ml) with
the standard curve obtained using the kit standards. When
indicated, CCL20/MIP-3 alpha and CCL5/RANTES levels
following short-term polarized infection for 4 h were also
evaluated by a custom semi-quantitative Human Cytokine
Antibody Array and fluorescent detection (RayBiotech, Inc.,
Norcross, GA), according to the manufacturer’s instructions.
CCL5/RANTES blocking experiments in foreskin explants,
epidermal single-cell suspensions and flow cytometry
Triplicate foreskin explants were pre-incubated for 30 min at
37uc with either 20 or 80 mg/ml of a goat-anti-human CCL5/
Figure 7. Schematized ‘chain-of-events’ of HIV-1 early entry in
the inner foreskin. At 1 h, HIV-1-infected cells form apical viral
synapses, which results in local HIV-1 budding, LCs attraction and HIV-1
capture (1). At 4 h, LCs migrate back towards the basement membrane
deeper into the tissue (2), in correlation with reduced CCL20/MIP-3
alpha secretion. At this time point, T-cells are recruited from the dermis
into the epidermis (3), as a result of increased CCL5/RANTES secretion,
and fuel the formation of LC-T-cell conjugates (4). Blocking CCR5 on T-
cells by clinically available CCR5 inhibitors may serve to limit T-cell
recruitment and local viral spread (5).
doi:10.1371/journal.ppat.1002100.g007
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compartments. Normal goat IgG (Santa Cruz Biotechnology,
Santa Cruz, CA) added at 40 mg/ml served as negative control.
Explants were then inoculated with HIV-1-infected or non-
infected PBMCs for 4 h as described above, and following removal
of the cloning ring cylinders, pooled tissue pieces were incubated
with their epidermal side facing up in 1 ml RPMI 1640 medium
supplemented with 2.4 U/ml Dispase II (Roche Diagnostics
GmbH, Mannheim, Germany) in a 12-wells plate overnight at
4uC. The epidermis and dermis were then mechanically separated
using forceps. Epidermal single-cell suspensions were prepared by
incubating pooled epidermal sheets from each triplicate in 1 ml
0.05% Trypsin/EDTA (Gibco) for 10 min at 37uC, followed by
inactivation of trypsin with 1 ml FBS, mechanical disruption using
a 10 ml pipette, filtration of released cells through a 40 mm nylon
cell strainer and centrifugation.
For surface staining of CD3 and langerin, epidermal cell
suspensions were resuspended in PBS and transferred to a 96
round-bottom wells plate (0.1–0.5610
6 cells/well). Cells were then
incubated for 30 min on ice with 10 mg/ml of PE-conjugated
mouse-anti-human CD3 (BD Pharmingen, San Jose, CA) and
APC-conjugated mouse-anti-human langerin (R&D) mAbs diluted
in PBS to a final volume of 50 ml/well. Cells were then washed,
centrifuged, and fixed for 15 min at room temperature with 4%
PFA. Cells stained with matched isotype control Abs served as
negative control. Fluorescence profiles were recorded using a
FACSCalibure and results were analyzed using the CellQuest Pro
software.
Confocal microscopy and immunohistochemistry
Following infection and fixation, foreskin explants were
embedded in paraffin. Serial 4 mm sections were cut, deparaffi-
nized in xylene and graded alcohol solutions, microwave heated in
10 mM citrate buffer pH=6.0 for antigen retrieval, cooled down
in the same buffer, and washed in PBS.
For confocal microscopy, sections were quenched with PBS/
50 mM glycine/75 mM ammonium chloride (Sigma, St. Louis,
MO) for 10 min at room temperature and blocked in PBS
containing 20% horse serum (HS, Vector Laboratories, Burlin-
game, CA) and 0.1% Tween-20 (Sigma) for 1 h at room
temperature. Following washes in PBS, sections were incubated
overnight at 4uc with primary Abs diluted in PBS/2% HS/0.1%
tween (50 ml/section), including goat-IgG-anti-human langerin at
20 mg/ml (R&D); mouse-IgG-anti-human CD3 at 10 mg/ml
(DakoCytomation, Glostrup, Denmark); a cocktail of several mouse
and human monoclonal Abs (5–10 mg/ml) recognizing HIV-1 gp41
(41A (Hybridolab, Pasteur Institute, Paris, France) 2F5, D50, 4E10
(NIH)), gp120 (2G12; NIH) and p24 (Kal-1; Dako). Sections were
then washed with PBS and incubated for 1 h at room temperature
with appropriate secondary Abs (50 ml/section, diluted 1:50–1:100
in PBS), including TRITC-conjugated anti-goat IgG (Beckman
Coulter, Villepinte, France) and FITC-conjugated anti-human/
mouse IgG (Jackson Immunoresearch, West Grove, PA), or
Alexa488-conjugated anti-goat IgG (Invitrogen, Cergy Pontoise,
France) and Cy5-conjugated anti-mouse IgG (Jackson). Cell nuclei
were then stained with DAPI (Sigma; 50 ml/section, 10 min at
room temperature), and the sections washed again in PBS and
mountedwithMOWIOLmedium(CalbiochemMerck,Darmstadt,
Germany), containing DABCO antifade (Sigma; 100 mg/ml).
Staining was visualized with Leica TCS SP or DMI6000
microscopes (Leica Microsystems, Wetzlar, Germany). Signals were
processed based on established parametric settings using specific
isotype controls [10]. Acquired image stacks were analyzed with
Imaris Software (Bitplane AG, Zurich, Switzerland). Image
deconvolution processing was performed by the Maximal Likeli-
hood Estimate procedure of the Huygens software (Scientific
Volume Imaging BV, Hilversum, The Netherlands).
For immunohistochemistry, the VECTASTAIN Elite-ABC kit
(Vector) was used according to the manufacturer’s instructions.
Sections were quenched with 3% hydrogen peroxide for 10 min at
room temperature and blocked with PBS/3% HS for 20 min at
room temperature. All Abs, including mouse-IgG2b-anti-human
langerin (Abcam, Cambrige, UK) and mouse-IgG1-anti-human
CD3 (Dako), as well as appropriate matching isotype controls,
were diluted to 5–10 mg/ml in Ab diluent (Dako) and incubated
with tissue sections for 30 min at room temperature (50 ml/
section). After washing in PBS, sections were incubated with
appropriate biotinylated secondary Abs followed by HRP-
conjugated streptavidin (Vector; 30 ml/section, 20 min at room
temperature), and visualized with di-amino benzidine (DAB;
Dako), 3-amino-9-ethyl carbazole (AEC; Dako) or HistoGreen
(AbCys, Paris, France) peroxidase substrates. Sections were
counterstained for 30 sec with hematoxyline solution (Dako) and
mounted with aqueous MOWIOL or non-aqueous Vectamount
(Vector) media, according to the recommendations for each
substrate. For double antigen staining a similar protocol was used
with the addition of a quenching step using LinBlock (Abcys)
between the first and second antigen staining. Images were taken
using the 640 objective of a Nikon E800 microscope (Nikon,
Tokyo, Japan) equipped with a CCD QICAM camera (QImaging,
Surrey, BC, Canada). For cell quantification, the ImageJ software
(NIH) was used to count the number of positively stained cells in a
minimum of 10 separate fields/stained section, and to calculate
the surface of either the epidermis or dermis in each field.
Measurement of the distance between 100–200 LCs and the
mucosal surface was evaluated using the Arcgis V9.3 program
(ESRI, Redlands, CA), as described earlier [10].
Electron microscopy
Foreskin explants were fixed for 1 h with 3% glutaraldehyde.
Samples were then postfixed in 1% osmium tetroxide in 0.1 M
PBS and dehydrated in increasing graded alcochol solutions. After
10 min incubation in a mixture of 1:2 epoxy propane and epoxy
resin, the samples were embed in gelatine capsules with freshly
prepared epoxy resin and polymerized at 60uc for 24 h. Sections
(80 nm) were then cut with an ultramicrotome (Reichert Ultracut
S, Reichert Technologies, Depew, NY), stained with uranyl
acetate and Reynold’s lead citrate, and observed with a
transmission electron microscope (JEOL 1011, JEOL, Tokyo,
Japan), equipped with a GATAN numerical camera (Gatan,
Munich, Germany). Pictures were taken and digitalized with
Digital Micrograph software (Gatan, Munich, Germany).
Statistical analysis
Statistical significance was analyzed by the Student’s t-test.
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